SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001113423-17-000011
Filing Date
2017-03-21
Accepted
2017-03-20 17:32:52
Documents
14
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 6-K aeternazentaris-6kproxy2017.htm 6-K 17665
2 EXHIBIT 99.1 exhibit991mic2017.htm EX-99.1 940694
3 EXHIBIT 99.2 exhibit992formofproxy.htm EX-99.2 81647
4 a2017managementinform_image2.jpg GRAPHIC 90582
5 aeternazentarislogoa21.jpg GRAPHIC 14150
6 blacksquare.jpg GRAPHIC 967
7 computershare.jpg GRAPHIC 4273
8 datemonthyear.jpg GRAPHIC 1527
9 fax.gif GRAPHIC 3518
10 internet.gif GRAPHIC 2425
11 performancegrapha02.jpg GRAPHIC 50775
12 plus.jpg GRAPHIC 968
13 qrcode.jpg GRAPHIC 12220
14 telephonea01.gif GRAPHIC 2507
  Complete submission text file 0001113423-17-000011.txt   1289378
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1 843-900-3211
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-30752 | Film No.: 17702381
SIC: 2834 Pharmaceutical Preparations